Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 24 December 1999:
Vol. 286. no. 5449, pp. 2453 - 2454
DOI: 10.1126/science.286.5449.2453
Prev | Table of Contents | Next

Policy Forum

PUBLIC HEALTH:
Reducing Liver Cancer--Global Control of Aflatoxin

Sara Hale Henry, F. Xavier Bosch, Terry C. Troxell, P. Michael Bolger

Regulation of food safety at the international level poses challenges over and above those occurring within domestic borders. The recent use of a quantitative risk assessment (QRA) by the Codex Alimentarius, an organ of the World Health Organization, in the consideration of the risk posed by aflatoxin contamination of foods represents the first time that such an approach has been used at an international level. The political and health implications of the study relative to the implications of increased use of hepatitis vaccines are discussed.

S. H. Henry, P. M. Bolger, and T. C. Troxell are at the Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, Washington, DC 20204, USA. E-mail: SHenry@bangate.fda.gov. F. X. Bosch is in the Institut Catala d'Oncologia, Unitat d'Epidemiologia, Hospitalet del Llobregat, Barcelona, Spain. E-mail: X.Bosch@ico.scs.es

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Measurement of food and alcohol intake in relation to chronic liver disease.
W. L Wrieden and A. S Anderson (2009)
Statistical Methods in Medical Research 18, 285-301
   Abstract »    PDF »
Breast cancer resistance protein (Bcrp1/Abcg2) reduces systemic exposure of the dietary carcinogens aflatoxin B1, IQ and Trp-P-1 but also mediates their secretion into breast milk.
A. E.v. Herwaarden, E. Wagenaar, B. Karnekamp, G. Merino, J. W. Jonker, and A. H. Schinkel (2006)
Carcinogenesis 27, 123-130
   Abstract »    Full Text »    PDF »
Immunogenicity in humans of an edible vaccine for hepatitis B.
Y. Thanavala, M. Mahoney, S. Pal, A. Scott, L. Richter, N. Natarajan, P. Goodwin, C. J. Arntzen, and H. S. Mason (2005)
PNAS 102, 3378-3382
   Abstract »    Full Text »    PDF »
Human aflatoxicosis in developing countries: a review of toxicology, exposure, potential health consequences, and interventions.
J. H Williams, T. D Phillips, P. E Jolly, J. K Stiles, C. M Jolly, and D. Aggarwal (2004)
Am. J. Clinical Nutrition 80, 1106-1122
   Abstract »    Full Text »    PDF »
Aflatoxin B1 formamidopyrimidine adducts are preferentially repaired by the nucleotide excision repair pathway in vivo.
Y. O. Alekseyev, M. L. Hamm, and J. M. Essigmann (2004)
Carcinogenesis 25, 1045-1051
   Abstract »    Full Text »    PDF »
Mycotoxins.
J. W. Bennett and M. Klich (2003)
Clin. Microbiol. Rev. 16, 497-516
   Abstract »    Full Text »    PDF »
Surface Binding of Aflatoxin B1 by Lactic Acid Bacteria.
C. A. Haskard, H. S. El-Nezami, P. E. Kankaanpaa, S. Salminen, and J. T. Ahokas (2001)
Appl. Envir. Microbiol. 67, 3086-3091
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)